Alzheimer's disease and apolipoprotein E genotype in Western Australia: An autopsy-verified series

Medical Journal of Australia

Volumn 165, Issue 2, 1996, Pages 77-80

  Fabian, Victoria A ^a,b   Jones, Thomas M ^a,b   Wilton, Stephen D ^a   Dench, Joanne E ^a,b   Davis, Mark R ^a,b   Lim, Lynnette ^a   Kakulas, Byron A ^a,b  

^a ROYAL PERTH HOSPITAL   (Australia)

^b Australian Neuromuscular Research Institute   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E4;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; AUSTRALIA; AUTOPSY; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENTORHINAL CORTEX; FEMALE; FRONTAL LOBE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENOTYPE; HIPPOCAMPUS; HISTOLOGY; HUMAN; MALE; PARIETAL LOBE; RETROSPECTIVE STUDY; RISK FACTOR; SENILE PLAQUE;

EID: 0029762447     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb124852.x     Document Type: Article

References (26)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-1981.
2. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-1472.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-923.
4. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995; 37: 118-120.
5. Tsuda T, Lopez R, Rogaeva EA, et al. Are the associations between Alzheimer's disease and polymorphisms in the apolipoprotein E and the apolipoprotein CII genes due to linkage disequilibrium? Ann Neurol 1994; 36: 97-100.
6. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994; 36: 656-659.
7. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993; 34: 752-754.
8. Elshourbagy NA, Liao WS, Mahley RW, Taylor JM. Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets. Proc Natl Acad Sci USA 1985; 82: 203-207.
9. Schemechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649-9653.
10. Rebeck GW, Harr SD, Strickland DK, Hyman BT. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the α2-macroglobulin receptor/low density lipoprotein receptor-related protein. Ann Neurol 1995; 37: 211-217.
11. Strittmatter WJ, Weisgraber KH, Huang DY, et al. Bindng of human apolipoprotein E to synthetic amyloid β peptide: isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098-8102
12. Nitsch RM, Rebeck GW, Deng M, et al. Cerebrospinal fluid levels of amyloid-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype. Ann Neurol 1995; 37: 512-518.
13. Han S, Hulette C, Saunders AM, et al. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls. Exp Neurol 1994; 128: 13-26
14. Strittmatter WJ, Weisgraber KH, Goedert M, et al. Hypothesis: microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype. Exp Neurol 1994; 125: 163-171.
15. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nature Genetics 1994; 7: 180-184.
16. Mirra SS, Heyman A, McKeel D, et al. The Consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
17. Bancroft JD, Stevens A. Theory and practice of histological techniques. 3rd ed. New York: Churchill Livingstone, 1990: 347.
18. Wilton S, Lim L. Rapid identification of APOE alleles by multiple single strand conformation polymorphism (SSCP) analysis. Trends Genet 1995; 11: 341.
19. Hyman BT, Terry RD. Apolipoprotein E, Ab, and Alzheimer disease. An editorial comment. J Neuropathol Exp Neurol 1994; 53: 427-428.
20. Henderson AS, Easteal S, Jorm AF, et al. Apolipoprotein E allele ε4, dementia, and cognitive decline in a population sample. Lancet 1995; 346: 1387-1390.
21. Hallman DM, Boerwinkle E, Saha N, et al. The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet 1991; 49: 338-349.
22. Sepehrnia B, Kamboh MI, Adams-Campbell LL, et al. Genetic studies of human apolipoproteins. The effect of the apolipoprotein E polymorphism on quantitative levels of lipoproteins in Nigerian blacks. Am J Human Genet 1989; 45: 586-591.
23. Gerdes LU, Klausen IC, Sihm I, Faergeman O. Apolipoprotein E polymorphism in a Danish population compared with findings in 45 other study populations around the world. Genet Epidemiol 1992; 9: 155-167.
24. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988; 8: 1-21.
25. Arriagada PV, Growdon J, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 1992; 42: 631-639.
26. Terry RD, Masliah E, Salmon D, et al. Physical basis of cognitive alterations in Alzheimer's disease Synapse loss is the major correlate of cognitive impairment. Ann Neurol 1991; 30: 572-580.